1. Scrip
  2. >>Business

Arix Says Latest Equity Raising May Be Last For Some Time As Exit Options Loom

 
• By Sten Stovall

Arix Bioscience's £87m equity raising brings to £250m the amount it has raised for incubating life sciences start-ups – but it might be the last for a while if portfolio 'exits' start generating cash, its CEO tells Scrip.

Startup button on a virtual screen touched by a businessman, concept about small fast growing businesses
Arix Aims To Invest In At Least Seven More Start-Ups By End-2018 • Source: Shutterstock

Just two years after its creation, incubator fund Arix Bioscience PLC has built a portfolio of 13 start-ups which could soon offer inflection points to realize the value of its investments through strategic exits.

That would reduce the need for another equity raising like the $87m financing just conducted, Arix's

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business